Teleflex Incorporated(TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Latest News & Analysis
Teleflex Delivers $2.03 Billion Portfolio Sale in Twenty-One Day Sprint
Definitive agreements for Acute Care, Interventional Urology, and OEM businesses validate accelerated separation strategy as shares surge thirteen percent.
Teleflex Accelerates Portfolio Split as Integration Strategy Crystallizes
Management unveils accelerated Nuco sale timeline at Jefferies conference, elevating BIOTRONIK integration to core RemainCo strategy amid analyst skepticism.
Teleflex Faces Analyst Reckoning as Guidance Cuts Signal Integration Caution
A third-quarter earnings beat masks concerns about execution as Wall Street downgrades to Reduce amid forward estimate revisions.
Teleflex Beats Q3 Earnings While Resetting Its Portfolio Strategy
The medical device maker delivers a strong operational performance and tightens guidance, navigating impairments that signal strategic consolidation.
Teleflex (TFX): Navigating Growth and Market Trends in 2025
An in-depth analysis of Teleflex developments, earnings, contracts, legal challenges, and expansion strategies shaping its future.
Teleflex: Developments, Market Impact, and Industry Trends
Teleflex faces mixed signals: Vizient contract boosts outlook, but legal probe looms. Earnings call and EMEA expansion in focus.